EU OTC Batch Testing Will Continue To Be Accepted In UK, For Now

Recognition of EU/EEA batch testing of imported medicines by UK will not be ending on 1 January 2023, and companies will be given two years notice if anything changes, says MHRA.

Brexit. Flags of the United Kingdom and the European Union to illustrate possible exit of Great Britain from the EU
• Source: Shutterstock

New regulations requiring OTC medicines imported from the European Union to be re-tested for quality control purposes before sale in the UK will not be introduced from January 2023 as originally planned, according to the UK’s Medicines and Healthcare products Regulatory Agency.

Companies affected will also be given two years notice if anything changes, the regulator adds, and nothing will change until...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe